Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Non-cash Items: 2019-2024

Historic Non-cash Items for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Dec 2024 value amounting to $5.0 million.

  • Arcturus Therapeutics Holdings' Non-cash Items fell 82.65% to $9.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.2 million, marking a year-over-year decrease of 82.65%. This contributed to the annual value of $5.0 million for FY2024, which is 34.65% up from last year.
  • According to the latest figures from FY2024, Arcturus Therapeutics Holdings' Non-cash Items is $5.0 million, which was up 34.65% from $3.7 million recorded in FY2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Non-cash Items peaked at $47.1 million during FY2021, and registered a low of $718,301 during FY2020.
  • Moreover, its 3-year median value for Non-cash Items was $5.0 million (2024), whereas its average is $6.5 million.
  • In the last 5 years, Arcturus Therapeutics Holdings' Non-cash Items skyrocketed by 6,458.67% in 2021 and then slumped by 77.24% in 2022.
  • Arcturus Therapeutics Holdings' Non-cash Items (Yearly) stood at $718,301 in 2020, then surged by 6,458.67% to $47.1 million in 2021, then tumbled by 77.24% to $10.7 million in 2022, then plummeted by 65.48% to $3.7 million in 2023, then surged by 34.65% to $5.0 million in 2024.